Cannabis Companies Demonstrate the Diverse Nature of the

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
1,047
Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market

NetworkNewsWire Editorial Coverage: The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020. The dollar amounts and projections may seem impressive, but they don’t tell the full story, as market demand is being fueled by an increasing number of applications. Medicinal marijuana is used to treat pain and inflammation, nausea, anxiety and diseases such as epilepsy and glaucoma. The medical community has also explored its cardiovascular health benefits and potential to reduce the incidence of diabetes, help people with Alzheimer’s disease and treat cancer. ChineseInvestors.com, Inc. (CIIX) (CIIX Profile) has added cannabis-based skincare products to the mix, as well as a Yelp-style app where products can be reviewed and discussed. It’s joined in the space by companies such as CV Sciences, Inc. (CVSI), Medical Marijuana, Inc. (MJNA), Terra Tech Corp. (TRTC) and MassRoots, Inc. (MSRT).

ChineseInvestors.com, Inc. (CIIX) is staking its position in the market with several product lines, including hemp-infused skin care products. Cannabis is known to have anti-inflammatory and antioxidant properties. The company noted the benefits in this area in an August 2017 press release (http://nnw.fm/z9WPp). They include improvements to skin complexion, thanks to the omega-3 and omega-6 fatty acids present in hemp seed oil. The fatty acids help keep skin moist and stimulate collagen production, helping skin to become firmer. In fact, the human endocannabinoid system includes cannabinoid receptors in the skin.

A recent press release (http://nnw.fm/Tb3Bi) highlights the scope of the company’s hemp-infused product line. CIIX’s wholly owned enterprise, CBD Biotechnology Co. Ltd., has completed the record filing process with the China FDA for the CBD Magic Hemp Series, a line of skin moisturizer, primer and peptide collagen solutions. These cannabidiol-infused products employ the antioxidant and anti-inflammatory benefits of CBD. The ability to sell these products is good news for investors.

Alan Klitenic, Director of Investor Relations for CIIX, was recently featured in an interview with SmallCapVoice.com (http://nnw.fm/flQB8) to discuss CIIX’s hemp-infused skin care line, as well as other company achievements.

“…We have manufactured this product: CBD Infused skin care products line with a design patent. This is a real milestone for us at ChineseInvestors.com. We are going to spend money and promote our CBD Hemp Oil and CBD infused skin care products in China going forward from now and thru 2018.” He also noted that the company is ready to start building distribution channels and begin retail sales, online commerce, social media, and direct marketing initiatives to maximize revenue and the value for shareholders.

Fully aware of the demand for medical cannabis, CIIX has worked to improve the user experience as well. It has developed an investing process, known as the ChineseInvestors Method, and introduced various web-based tools to disseminate market information to investors. That puts investors on the front lines of China’s $30 billion per year skin care product industry.

The company also developed and launched a Chinese-language social media app, approved for download via the Apple App Store. It enables users to view, discuss, and write reviews on cannabis strains and marijuana dispensaries. People can use the application’s maps to find retailers, view business summary reports and see product recommendations. Social media isn’t CIIX’s only strategy, as a recent partnership with the digital agency Launch Haus LLC has spawned a marketing campaign aimed at expanding CIIX’s direct-to-consumer e-commerce business. It also appointed Keevin Gillespie as acting president of ChineseHelpOil.com, Inc., a wholly-owned subsidiary of CIIX, to brand and promote the OptHemp health product line.

As active as the company has been in the cannabis space, it is not the only mover in a fast-growing and diversifying market.

Another company with a diverse product line is CV Sciences (CVSI). Its pipeline consists of CVSI-007, a smokeless tobacco cessation product. The drug candidate comes in the form of a chewing gum, which contains nicotine and synthetic CBD. Consumer products already on the market include PlusCBD Oil, a dietary supplement sold in capsules, sprays, balms, drops, concentrates and vape liquid in nearly 1,000 retail locations. Vape blends are sold via CVSI’s Purified Liquids store, while cannabinoids are sold wholesale to serve the growing CBD wellness market. The company recently presented at the Natural Products Expo East 2017, in Baltimore, Maryland, and the MJAC2017 InvestorsHub International Cannabis Conference in Los Angeles, California.

The international cannabis market is also experiencing considerable growth, and Medical Marijuana (MJNA) distinguishes itself as the first publicly traded cannabis company in the U.S. and the first to introduce legal medical cannabis in Brazil. Its e-commerce store sells numerous brands and categories of CBD oil, including capsules, isolates, chewing gum, vape oil, vaporizer pens and body lotions and creams. In addition to pen-type vaporizers, the company also sells portable and tabletop units, as well as an electric dabbing system for vaporizing medical concentrates. All products are sold as dietary supplements rather than medical marijuana, so they can be purchased legally without doctor recommendations.

Terra Tech (TRTC) supplies the medical cannabis market via brands such as IVXX™, a cultivator and producer of different concentrates and other products, and Edible Garden®, which uses Dutch hydroponic farming methods to produce Global Food Safety Initiative-certified products, including a wide range of herbs and leafy greens. The company therefore serves the food industry as well, but it also specializes in high-grade medical cannabis that is produced at its Blüm™ facility. In addition, Terra Tech’s MediFarm division manages the permit application and procurement process for marijuana cultivators, while GrowOp Technology designs and manufactures horticultural equipment and automation/control software.

MassRoots (MSRT) offers an extremely diverse product line via its online catalog. Searchable by plant type, flavors, effects, health conditions, and manufacturer, it gives customers one of the most simple and comprehensive sources of edibles, lotions, drops and more. The company’s website has an educational article section plus a news page with frequent updates. Another resource featured on the site is a local dispensary search function, but the company also serves other businesses, providing a connection with point-of-sale systems that enable retailers to display their inventory in real time and provide customers with simple online ordering.

Cannabis companies are serving a fast-growing and diversifying market by various means. The skincare and healthcare products and social app from ChineseInvestors.com, Inc. (CIIX) are prime examples. The products and services of the companies discussed above have become relevant in the current business climate and show potential to keep pace with broader industry growth.

For more on ChineseInvestors.com please visit: ChineseInvestors.com, Inc. (CIIX)

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Chineseinvestors.com Inc. (CIIX) Stock Research Links

CIIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 0

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 1

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 4

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
ing Brands Faces Legal Probe; Fiduciary Duties Questioned"> Continue Reading